Skip to main content
Signal8

Health In Tech, Inc. (HIT) Form 8-K — Nov 18, 2026

$HITForm 8-KItems 5.02, 7.01, 9.01Filed Nov 18, 2026, 6:35 AM ET0001213900-26-121570Original filing

Health In Tech (Nasdaq: HIT) filed an 8-K confirming the addition of two independent directors: Tim Cortes (elected by stockholders effective November 10, 2026) and CEO Sanjay Shrestha and Christina R. Valauri (appointed effective November 12, 2026). Valauri brings over 30 years of Wall Street experience including senior roles at Cantor Fitzgerald, Natixis, ING Barings and Crédit Lyonnais, and was ranked No. 1 in biomedical/biotechnology in the WSJ "Best on the Street" analyst survey.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.